10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:213
Name:Compound 213
Description:Original numeration in publication: 10i
Labels:Training_set, Quinazolines
CAS:
InChi Code:InChI=1S/C23H17N7O2/c31-20-8-4-1-5-16(20)13-24-29-22(32)15-9-11-17(12-10-15)26-23-27-19-7-3-2-6-18(19)21-28-25-14-30(21)23/h1-14,31H,(H,26,27)(H,29,32)/b24-13+

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
7.01

Abdallah, A. E.; Eissa, S. I.; Al Ward, M. M. S.; Mabrouk, R. R.; Mehany, A. B. M. a. E.-Z., M. A. Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation. Bioorg. Chem. 2021, 109, 104695. https://doi.org/10.1016/j.bioorg.2021.104695

6.67587

Eq1: VEGFR-2 inhibition (Data used to train model)